The changing landscape of invasive fungal infections: Epidemiology, diagnosis, and pharmacologic options

Clinical Infectious Diseases

Volumn 43, Issue SUPPL. 1, 2006, Pages

  Kauffman, Carol A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; CORTICOSTEROID; ECHINOCANDIN; FUNGUS ANTIGEN; GALACTOMANNAN; GLUCAN; MICAFUNGIN; POSACONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ANTIGEN DETECTION; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST; DRUG FORMULATION; DRUG SENSITIVITY; EDITORIAL; FUNGUS CULTURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MYCOSIS; NONHUMAN; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; RISK FACTOR; TOXIC HEPATITIS; VISUAL DISORDER;

EID: 33746095427     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/504489     Document Type: Editorial

References (3)

1. Pfeller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006; 43(Suppl 1): S3-14 (in this supplement).
2. Alexander BD, Pfaller MA. Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis 2006; 43(Suppl 1): S15-27 (in this supplement).
3. Dodds Ashley ES, Lewis R, Lewis JS, Martin C, Andes D. Pharmacology of systemic antifungal agents. Clin Infect Dis 2006; 43(Suppl 1): S28-39 (in this supplement).